GLOW Blend (BPC-157 GHK-Cu TB-500) GLOW blend (BPC-157 GHK-Cu TB-500) lyophilized tri-peptide research blend, third-party tested with a Certificate of Analysis (COA)
There is no validated dosing, safety, or monitoring protocol for BPC-157 in dogs, and it is a research-use-only compound not approved for animal treatment
Because of its size and location, its often considered one of the most comfortable and effective spots, making it a top choice in a clinical environment to ensure you get the maximum benefit from your treatment
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
However, recognising when symptoms warrant further assessment ensures safe, effective treatment
The peptide can be delivered via injection or other routes recommended by your physician